DIRAS3 (ARHI) Blocks RAS/MAPK Signaling by Binding Directly to RAS and Disrupting RAS Clusters-Reference-Cited by-同舟云学术

DIRAS3 (ARHI) Blocks RAS/MAPK Signaling by Binding Directly to RAS and Disrupting RAS Clusters

Published:2019-12 Issue:11 Volume:29 Page:3448-3459.e6
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Sutton Margie N.,Lu Zhen,Li Yao-Cheng,Zhou Yong,Huang Tao,Reger Albert S.,Hurwitz Amy M.,Palzkill Timothy,Logsdon Craig,Liang Xiaowen,Gray Joe W.,Nan Xiaolin,Hancock John,Wahl Geoffrey M.,Bast Robert C.

Funder

MD Anderson SPOREs in Ovarian Cancer

National Cancer Institute

Cancer Prevention and Research Institute of Texas

Shared Resources of the MD Anderson CCSG

The National Foundation for Cancer Research

Anne and Henry Zarrow Foundation

Stuart and Gaye-Lynn Zarrow

Mossy Foundation

Roberson endowment

NIH

American Legion Auxiliary

Ovarian Cancer Research Fund Alliance

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference42 articles.

1. KRAS Dimerization Impacts MEK Inhibitor Sensitivity and Oncogenic Activity of Mutant KRAS;Ambrogio;Cell,2018

2. The tumor-suppressor gene ARHI (DIRAS3) suppresses ovarian cancer cell migration through inhibition of the Stat3 and FAK/Rho signaling pathways;Badgwell;Oncogene,2012

3. Stochastic optical reconstruction microscopy (STORM): a method for superresolution fluorescence imaging;Bates;Cold Spring Harb. Protoc.,2013

4. Biological assays for Ras transformation;Clark;Methods Enzymol.,1995

5. Low expression of ARHI is associated with shorter progression-free survival in pancreatic endocrine tumors;Dalai;Neoplasia,2007

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The ubiquitin-proteasome system in the regulation of tumor dormancy and recurrence;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-07

2. Intrinsically Disordered Membrane Anchors of Rheb, RhoA, and DiRas3 Small GTPases: Molecular Dynamics, Membrane Organization, and Interactions;The Journal of Physical Chemistry B;2024-06-28

3. Driver Mutations in Pancreatic Cancer and Opportunities for Targeted Therapy;Cancers;2024-05-09

4. The UBE2F-CRL5ASB11-DIRAS2 axis is an oncogene and tumor suppressor cascade in pancreatic cancer cells;Developmental Cell;2024-05

5. Intrinsically disordered membrane anchors of Rheb, RhoA and DiRas3 small GTPases: Molecular dynamics, membrane organization, and interactions;2024-04-28